A detailed history of Jane Street Group, LLC transactions in Morpho Sys Ag stock. As of the latest transaction made, Jane Street Group, LLC holds 45,682 shares of MOR stock, worth $826,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,682
Previous 102,420 55.4%
Holding current value
$826,844
Previous $1.01 Million 18.26%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$8.6 - $18.18 $487,946 - $1.03 Million
-56,738 Reduced 55.4%
45,682 $828,000
Q4 2023

Feb 14, 2024

BUY
$4.55 - $9.9 $466,011 - $1.01 Million
102,420 New
102,420 $1.01 Million
Q1 2022

May 17, 2022

SELL
$5.87 - $9.73 $248,518 - $411,939
-42,337 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$9.08 - $12.45 $384,419 - $527,095
42,337 New
42,337 $402,000
Q3 2021

Nov 16, 2021

SELL
$11.76 - $19.51 $499,764 - $829,116
-42,497 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$18.95 - $23.95 $805,318 - $1.02 Million
42,497 New
42,497 $823,000
Q1 2021

May 18, 2021

SELL
$21.56 - $30.66 $653,181 - $928,875
-30,296 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$24.81 - $30.33 $751,643 - $918,877
30,296 New
30,296 $868,000
Q3 2020

Nov 17, 2020

SELL
$30.28 - $35.72 $274,336 - $323,623
-9,060 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$24.08 - $33.35 $218,164 - $302,151
9,060 New
9,060 $286,000
Q4 2019

Feb 14, 2020

SELL
$26.07 - $36.32 $717,394 - $999,453
-27,518 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$24.18 - $31.58 $21,858 - $28,548
-904 Reduced 3.18%
27,518 $756,000
Q2 2019

Aug 15, 2019

BUY
$23.24 - $26.76 $84,384 - $97,165
3,631 Added 14.65%
28,422 $680,000
Q1 2019

May 16, 2019

SELL
$22.55 - $29.84 $45,054 - $59,620
-1,998 Reduced 7.46%
24,791 $563,000
Q4 2018

Feb 15, 2019

BUY
$21.96 - $31.02 $243,228 - $343,577
11,076 Added 70.49%
26,789 $683,000
Q3 2018

Nov 14, 2018

BUY
$26.64 - $35.66 $418,594 - $560,325
15,713 New
15,713 $417,000

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Market Cap $2.47B
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.